Cellectis Est. EPS Q / Q
¿Qué es el Est. EPS Q / Q de Cellectis?
El Est. EPS Q / Q de Cellectis es -45.12%
¿Cuál es la definición de Est. EPS Q / Q?
La tasa de crecimiento prospectiva trimestral del EPS, año tras año, es el aumento estimado del EPS de la compañía para el próximo trimestre en comparación con el comportamiento de un trimestre correspondiente anterior.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q / Q de compañías en Sector Health Care en NASDAQ en comparadas con Cellectis
¿Qué hace Cellectis?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Empresas con est. eps q / q similar a Cellectis
- Banco Macro S.A tiene Est. EPS Q / Q de -45.38%
- American International Inc tiene Est. EPS Q / Q de -45.36%
- Western Union tiene Est. EPS Q / Q de -45.31%
- Passage Bio Inc tiene Est. EPS Q / Q de -45.26%
- Teradyne tiene Est. EPS Q / Q de -45.26%
- Avanti Feeds tiene Est. EPS Q / Q de -45.24%
- Cellectis tiene Est. EPS Q / Q de -45.12%
- Companhia Siderurgica Nacional tiene Est. EPS Q / Q de -45.00%
- Copperleaf Technologies tiene Est. EPS Q / Q de -45.00%
- Unity Biotechnology Inc tiene Est. EPS Q / Q de -45.00%
- Nano Dimension Ltd tiene Est. EPS Q / Q de -45.00%
- PLx Pharma tiene Est. EPS Q / Q de -45.00%
- BXP tiene Est. EPS Q / Q de -44.92%